The applicability of pions to cancer radiotherapy, 2
Creators
- 1. Univ. of Occupational and Environmental Health, Fukuoka (Japan)
Description
A theoretical analysis was attempted to give a remaining number of π meson, N(X), as function of depth X in a target, lucite as model, under a beam of π meson. Under the assumption of three different elementary processes, π-e Rutherford scattering, π-decay and π-nucleus interaction, N(X) was theoretically evaluated. It was shown that the estimated stopped points of π particles agreed well with the experimentally obtained data if the π-e Rutherford scatterings were the main cause of π momentum reduction. Since the decay of π meson is negligible in the reduction of π meson, N (X) is mainly due to π-nucleus reaction in the region of a small depth but it is due to π-nucleus Rutherford scattering at a point less than 1.5 cm before the stopped point of π. (author)
Additional details
Additional titles
- Subtitle (English)
- Theoretical analysis of the capture and absorption of pions in polymer
Publishing Information
- Journal Title
- Sangyo Ika Daigaku Zasshi
- Journal Volume
- 5
- Journal Issue
- 2
- Series
- Sangyo Ika Daigaku Zasshi.
- Journal Page Range
- 235-241
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 15052974
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ABSORPTION; ABSORPTION SPECTRA; CAPTURE; DEPTH DOSE DISTRIBUTIONS; ENERGY LEVELS; ENERGY LOSSES; LUCITE; PARTICLE DECAY; PHANTOMS; PION MINUS REACTIONS; PIONS MINUS; RADIOTHERAPY; RANGE; RUTHERFORD SCATTERING
- Descriptors DEC
- ANTIMATTER; ANTIMESONS; ANTIPARTICLES; BOSONS; DECAY; DISTRIBUTION; ELASTIC SCATTERING; ELEMENTARY PARTICLES; ESTERS; HADRON REACTIONS; HADRONS; MATTER; MEDICINE; MESON REACTIONS; MESONS; MOCKUP; NUCLEAR REACTIONS; ORGANIC COMPOUNDS; ORGANIC POLYMERS; PION REACTIONS; PIONS; POLYACRYLATES; POLYMERS; POLYVINYLS; PSEUDOSCALAR ANTIMESONS; PSEUDOSCALAR MESONS; RADIATION DOSE DISTRIBUTIONS; SCATTERING; SPATIAL DISTRIBUTION; SPATIAL DOSE DISTRIBUTIONS; SPECTRA; STRUCTURAL MODELS; THERAPY